Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
19 hedge funds and large institutions have $6.75M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
91% more capital invested
Capital invested by funds: $3.54M → $6.75M (+$3.21M)
12% more funds holding
Funds holding: 17 → 19 (+2)
80% less call options, than puts
Call options by funds: $78K | Put options by funds: $395K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$52.3K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$50.5K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$47.9K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$40.7K |
| 5 |
Renaissance Technologies
New York
|
+$23.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$31.9K |
| 2 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$20K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$409 |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$369 |
CORV Hedge Fund Activity: Q3 2013 in Review
19 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q3 2013, worth a combined $6.75M — up 91% from $3.54M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CORV positions and 1 closed out — a net gain of 3 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $52.3K. The largest seller was TFS Capital, cutting an estimated $31.9K.
- 19 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q3 2013, up from 17 in Q2 2013.
- Funds reported $6.75M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q3 2013, up 91% quarter-over-quarter.
- 4 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q3 2013 and 1 closed out, a net change of +3 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q3 2013 was Susquehanna International Group, an estimated $52.3K added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q3 2013 was TFS Capital, an estimated $31.9K sold.
Based on aggregated 13F filings for Q3 2013.